Vaccination in Individuals with Multiple Sclerosis – Part II

Aslı Tuncer1, Bilge Piri Çınar2, Nuray Bilge3, Sena Destan Bünül4, Rabia Gökçen Gözübatık Çelik5, Eda Derle Çiftçi6, Gencer Genç7, Bedriye Karaman8, Ahmet Kasım Kılıç9, Alp Sarıteke10, Meral Seferoğlu11, Ali Özhan Sıvacı11, Bedile İrem Tiftikçioğlu12, Abdulkadir Tunç13, Gülgün Uncu14, İrfan Yavaş15, Mehmet Fatih Yetkin16, Hüsnü Efendi4, Aksel Siva17

1Hacettepe University Faculty of Medicine, Department of Neurology, Ankara, Türkiye
2Samsun University Faculty of Medicine, Department of Neurology, Samsun, Türkiye
3Ataturk University Faculty of Medicine, Department of Neurology, Erzurum, Türkiye
4Kocaeli University Faculty of Medicine, Department of Neurology, Kocaeli, Türkiye
5University of Health Sciences Türkiye, Istanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, Türkiye
6Baskent University Faculty of Medicine, Department of Neurology, Ankara, Türkiye
7University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Clinic of Neurology, Istanbul, Türkiye
8Ege University Faculty of Medicine, Department of Neurology, Izmir, Türkiye
9Kartal Dr. Lutfi Kirdar Training and Research Hospital, Clinic of Neurology, Istanbul, Türkiye
10University of Health Sciences Türkiye, Izmir Tepecik Training and Research Hospital, Clinic of Neurology, Izmir, Türkiye
11Bursa Yüksek İhtisas Training and Research Hospital, Clinic of Neurology, Bursa, Türkiye
12Bakircay University Training and Research Hospital, Clinic of Neurology, Izmir, Türkiye
13Sakarya University Training and Research Hospital, Clinic of Neurology, Sakarya, Türkiye
14Eskisehir City Hospital, Clinic of Neurology, Eskisehir, Türkiye
15Karabuk University Faculty of Medicine, Department of Neurology, Karabuk, Türkiye
16Erciyes University Faculty of Medicine, Department of Neurology, Kayseri, Türkiye
17Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul, Türkiye

Keywords: Multiple sclerosis, vaccination, safety

Abstract

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient. Since vaccination can be performed at any stage of life, immune system activity should be reviewed in patients with MS except where it is characteristic of the vaccine. In this review, the applications of different vaccines in patients with MS are discussed in two separate sections (part 1 was published in the previous issue).

Peer Review

Externally peer-reviewed.

Author Contributions

Concept: A.T., B.P.Ç., Al.S., H.E., Design: B.P.Ç., A.T., A.S., Data Collection or Processing: All authors, Analysis or Interpretation: B.İ.T., B.P.Ç., A.T., Ak.S., H.E., Literature Search: All authors, Writing: B.P.Ç., A.T.

Conflict of Interest

No conflict of interest was declared by the authors.

Financial Disclosure

The authors declared that this study received no financial support.